A comparison of ML Flow serology and slit skin smears to assess the bacterial load in newly diagnosed leprosy patients in Brazil

Leprosy Review

Volumn 79, Issue 2, 2008, Pages 162-170

  Lyon, Sandra ^a,b,e   Lyon, Ana Claudia ^a,b   Da Silva, Rozana Castorina ^a,b   Grossi, Maria Aparecida De Faria ^b,c   Lyon, Silvia Helena ^a   Bührer Sékula, Samira ^d,f   Rocha, Manoel O C ^b  

^a FUNDAÇÃO HOSPITALAR DO ESTADO DE MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Technical Coordination in Leprosy of Minas Gerais Health State Ministry

^d ROYAL TROPICAL INSTITUTE   (Netherlands)

^e Federal University of Goiás ^*  (Brazil)

^f FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOLIC GLYCOLIPID I;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZIL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ML FLOW TEST; MULTIBACILLARY LEPROSY; MULTIVARIATE ANALYSIS; PAUCIBACILLARY LEPROSY; PERIPHERAL NERVE; SEROLOGY; SKIN DEFECT; SLIT SKIN SMEAR; WORLD HEALTH ORGANIZATION;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; BRAZIL; FEMALE; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN M; LEPROSY; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM LEPRAE; SKIN; STAINING AND LABELING;

EID: 51349141267     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. World Health Organization. A guide to eliminating leprosy as a public health problem. WHO/LEP/97.7. 2. ed. Geneva, 1997.
2. Bührer-Sékula S, Smits HL, Gussenhoven GC et al. Simple and fast lateral Flow Test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol, 2003; 41: 1991-1995.
3. Ridley DS, Jopling WH. Classification of leprosy according to immunity: five group system. Int J Lepr, 1966; 34: 255-273.
4. Norman G, Joseph G, Richard J. Validity of the WHO operational classification and value of other clinical signs in the classification of leprosy. Int J Lepr, 2004; 72: 278-283.
5. Gallo MEN, Ramos LAN, Jr, Albuquerque ECA et al. Alocação do paciente hanseniano na poliquimioterapia: correlação da classificação baseada no número de lesões cutâneas com os exames baciloscópicos. An Bras Dermatol, 2003; 78: 415-424 (http://www.scielo.br/scielo.php?script= sci_abstract&pid=S0365-05962003000400003&lng=en&nrm=iso&tlng=en) .
6. Castorina-Silva R. Efeitos adversos mais freqüentes das drogas em uso para o tratamento da hanseníase e suas implicações no controle da endemia. Dissertação (Mestrado). Faculdade de Medicina, UFMG, 2003.
7. Oskam L, Slim E, Bührer-Sékula S. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev, 2003; 74: 196-205.